CONVERGENCE BIO Trademark

Trademark Overview

On Thursday, May 30, 2024, a trademark application was filed for CONVERGENCE BIO with the United States Patent and Trademark Office. The USPTO has given the CONVERGENCE BIO trademark a serial number of 98576548. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, May 6, 2026. This trademark is owned by Convergence Bio, Inc.. The CONVERGENCE BIO trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations, vaccines, and medical therapeutic pharmaceuticals for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; medical therapeutics in the form of medicines and medical preparations for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations, vaccines, and medical therapeutic pharmaceuticals for the prevention and treatment of blood disorders, bone disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; medical therapeutics in the form of medic...

research and development services in the field of pharmaceutical preparations, vaccines and therapeutic drugs for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; research and development services of new pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals relating to therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; research and development of new pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals relating to therapeutic modalities for treatment of aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointesti...

assays and reagents for use in scientific and biomedical research
convergence bio

General Information

Serial Number98576548
Word MarkCONVERGENCE BIO
Filing DateThursday, May 30, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, May 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2026

Trademark Statements

NOT AVAILABLE"BIO"
Goods and Servicespharmaceutical preparations, vaccines, and medical therapeutic pharmaceuticals for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; medical therapeutics in the form of medicines and medical preparations for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations, vaccines, and medical therapeutic pharmaceuticals for the prevention and treatment of blood disorders, bone disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; medical therapeutics in the form of medicines and medical preparations for the prevention and treatment of blood disorders, bone disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; vaccines for human use; pharmaceutical preparations, vaccines, and medical therapeutic pharmaceuticals for improving the aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss; medical therapeutics in the form of medicines and medical preparations for improving the aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss; nutritional and dietary supplements for improving the aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss
Goods and Servicesresearch and development services in the field of pharmaceutical preparations, vaccines and therapeutic drugs for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; research and development services of new pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals relating to therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; research and development of new pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals relating to therapeutic modalities for treatment of aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss; development of pharmaceutical preparations, vaccines and medicines; medical research for development of therapeutic modalities for treatment of diseases; pharmaceutical, vaccine, medical therapeutic, and medical therapeutic pharmaceutical drug development and discovery; clinical studies in the nature of medical research services and conducting clinical trials for others; clinical studies, namely, clinical research in the field of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; preclinical and clinical development of therapeutic products, namely, development of medicines, pharmaceutical preparations, vaccines, medical therapeutics, and medical therapeutic pharmaceuticals
Goods and Servicesassays and reagents for use in scientific and biomedical research

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, April 28, 2026
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 30, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameConvergence Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02199
US

Trademark Events

Event DateEvent Description
Thursday, May 30, 2024NEW APPLICATION ENTERED
Wednesday, August 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 12, 2024ASSIGNED TO EXAMINER
Thursday, January 2, 2025NON-FINAL ACTION WRITTEN
Thursday, January 2, 2025NON-FINAL ACTION E-MAILED
Thursday, January 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 5, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, March 5, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, July 2, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 2, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 2, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 27, 2025FINAL REFUSAL WRITTEN
Monday, October 27, 2025FINAL REFUSAL E-MAILED
Monday, October 27, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 27, 2026APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, January 27, 2026APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, April 27, 2026EXPARTE APPEAL RECEIVED AT TTAB
Monday, April 27, 2026JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, April 27, 2026EX PARTE APPEAL-INSTITUTED
Monday, April 27, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 27, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 27, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 27, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 29, 2026EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 29, 2026EXAMINERS AMENDMENT E-MAILED
Wednesday, April 29, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 29, 2026EXAMINER'S AMENDMENT ENTERED
Wednesday, April 29, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

convergence medical therapeutic disorders system pharmaceuticals preparations research vaccines treatment pharmaceutical